The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women

INTRODUCTION: AIB1, located at 20q12, is a member of the steroid hormone coactivator family. It contains a glutamine repeat (CAG/CAA) polymorphism at its carboxyl-terminal region that may alter the transcriptional activation of the receptor and affect susceptibility to breast cancer through altered...

Descripción completa

Detalles Bibliográficos
Autores principales: Montgomery, Karen G, Chang, Jiun-Horng, Gertig, Dorota M, Dite, Gillian S, McCredie, Margaret R, Giles, Graham G, Southey, Melissa C, Hopper, John L, Campbell, Ian G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143559/
https://www.ncbi.nlm.nih.gov/pubmed/15987430
http://dx.doi.org/10.1186/bcr1009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143559/
https://www.ncbi.nlm.nih.gov/pubmed/15987430
http://dx.doi.org/10.1186/bcr1009

Ejemplares similares